MAQS has advised Oblique Therapeutics AB (publ). Oblique Therapeutics AB (publ) has announced the issuance of convertible bonds with a total value of approximately SEK 15.2...
Oblique Therapeutics Issues Convertible Bonds Worth SEK 15.2 Million
Oblique Therapeutics’ SEK 53.2 Million Rights Offering
MAQS advised Oblique Therapeutics on the deal. Oblique Therapeutics AB (publ) completed a rights issue of approximately SEK 53.2 million. Oblique Therapeutics is a privately held...


























